Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Xu N, Yang XF, Xue SL, Tan JW, et al. Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells. Biochem Biophys Res Commun 2022;595:54-61.
PMID: 35101664


Privacy Policy